MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjopen-2016-011179

Медицинская библиотека · BMJ open · 2017

Comparison of enteral versus intravenous potassium supplementation in hypokalaemia in paediatric patients in intensive care post cardiac surgery: open-label randomised equivalence trial (EIPS).

Rehman Siddiqu Naveed Ur, Merchant Quratulain, Hasan Babar S, Rizvi Arjumand, Amanullah Muneer, Rehmat Amina, Ul Haq Anwarul

Клиническое исследование IV фазыСравнительное исследованиеEquivalence TrialСтатьяПеревод в очереди

Аннотация

OBJECTIVES

The primary objective was to compare the efficacy of enteral potassium replacement (EPR) and intravenous potassium replacement (IVPR) as first-line therapy. Secondary objectives included comparison of adverse effects and number of doses required to resolve the episode of hypokalaemia.

TRIAL

DESIGN

The EIPS trial is designed as a randomised, equivalence trial between two treatment arms.

STUDY

SETTING

The study was conducted at the paediatric cardiac intensive care unit (PCICU) at Aga Khan University Hospital, Karachi.

PARTICIPANTS

41 patients (aged 1 month to 15 years) who were admitted to PCICU post cardiac surgery were recruited (23 IVPR arm and 18 EPR arm).

INTERVENTION: Intervention arms were block randomised on alternate weeks for IVPR and EPR.

OUTCOME MEASURE: Change in serum potassium levels in (mmol/L) and percentage change after each event of potassium replacement by the intravenous or enteral route.

RESULTS

Both groups (41 patients) had similar baseline characteristics. Mean age was 4.7 (SD±4) years while the most common surgical procedure was ventricular septal defect repair (12 patients, 29.3%). No mortality was observed in either arm. Four episodes of vomiting and one arrhythmia were seen in the EPR group. After adjusting for age, potassium level at the beginning of the episode, average urine output, inotropic score and diuretic dose, it was found that there was no statistically significant difference in change in potassium levels after EPR and IVPR: 0.86 mmol/L (±0.8) and 0.82 mmol/L (±0.7) respectively (p=0.86, 95% CI -0.08 to 1.10), or percentage change in potassium level after enteral and intravenous replacement: 26% (±30) and 24% (±20) (95% CI -3.42 to 4.03, p=0.87).

CONCLUSION

EPR may be an equally efficacious alternative first-line therapy in treating hypokalaemia after surgery in selective patients with congenital heart disease.

ETHICS AND DISSEMINATION: This study has been approved by Ethics Review Committee at AKU.

TRIAL REGISTRATION NUMBER: NCT02015962.

Для цитирования: Rehman Siddiqu Naveed Ur, Merchant Quratulain, Hasan Babar S, Rizvi Arjumand, Amanullah Muneer, Rehmat Amina, Ul Haq Anwarul. Comparison of enteral versus intravenous potassium supplementation in hypokalaemia in paediatric patients in intensive care post cardiac surgery: open-label randomised equivalence trial (EIPS).. BMJ open. 2017. DOI: 10.1136/bmjopen-2016-011179.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.